Effects of Glimepiride vs Glibenclamide on Ischaemic Heart Disease Risk Factors and Glycaemic Control in Patients with Type 2 Diabetes Mellitus

Author： Britton M.E.   denver A.E.   Mohamed-Ali V.   Yudkin J.S.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.16, Iss.4, 1998-10, pp. : 303-317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pioglitazone provides greater long-term glycaemic control than glibenclamide [glyburide] in patients with type 2 diabetes mellitus (T2DM)

By  

Inpharma, Vol. 1, Iss. 1544, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

A fixed combination of rosiglitazone plus metformin improves glycaemic control and cardiovascular risk factors in patients with type 2 diabetes mellitus (T2DM)

By  

Inpharma, Vol. 1, Iss. 1546, 2006-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Effects on Blood Pressure of the -Glucosidase Inhibitor Acarbose Compared with the Insulin Enhancer Glibenclamide in Patients with Hypertension and Type 2 Diabetes Mellitus

By Rosenthal J.H.   Mauersberger H.  

Clinical Drug Investigation, Vol. 22, Iss. 10, 2002-01 ,pp. : 695-701

Adis International

Access to resources Recommend Favorite

Optimisation of the Management of Patients with Coronary Heart Disease and Type 2 Diabetes Mellitus

By Wilson S.H.   Kennedy F.P.   Garratt K.N.  

Drugs & Aging, Vol. 18, Iss. 5, 2001-01 ,pp. : 325-333

Adis International

Access to resources Recommend Favorite

Glycaemic control was markedly improved by pioglitazone in a patient with type 2 diabetes mellitus associated with Charcot-Marie-Tooth disease

By  

Inpharma, Vol. 1, Iss. 1393, 2003-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite